Lisa Littman, of "ROGD" infamy, now conjures another clinical entity out of thin air: "young adult-onset gender dysphoria"

Another NHS clinician, Michael Absoud, the "deputy chief investigator for the proposed puberty blocker trial". SEGM associates are defining the terms on which our gender-affirming care is studied